Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC17765Naftopidil DiHClCAS: 57149-08-3
Naftopidil DiHCl (KT-611 dihydrochloride) 是一种选择性 alpha1-adrenoceptor 拮抗剂,对克隆人 α1a-, ⋱1b- 和 α1d-adrenoceptor subtypes 的 Kis 分别为 3.7 nM,20 nM 和 1.2 nM。 Naftpidil DiHCl 具有抗增殖作用。 Naftpidil DiHCl可用于前列腺增生的研究。
- GC17769Sitaxentan sodiumCAS: 210421-74-2纯度: >98.00%
Sitaxentan sodium是一种选择性内皮素A受体(ETA)拮抗剂(IC 50 = 1.4nM;K i = 0.43nM)。
- GC17776AsaraldehydeCAS: 4460-86-0纯度: >99.50%
Asarylaldehyde (Asaronaldehyde) 是一种 COX-2 抑制剂,可显着抑制环氧合酶 II (COX-2) 的活性,IC50 值为 100 μg/mL。
- GC17783Veliparib dihydrochlorideCAS: 912445-05-7纯度: >99.50%
An orally bioavailable inhibitor of PARP1 and PARP2
- GC17836ITF2357 (Givinostat)CAS: 732302-99-7纯度: >98.00%
HDAC inhibitor with anti-inflammatory and antineoplastic activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC17760 | Clozapine | 5786-21-0 | >98.00% | |
An atypical antipsychotic | ||||
| GC17762 | NSC 33994 | 82058-16-0 | - | |
NSC 33994 (G6) 是一种选择性 JAK2 抑制剂,IC50 为 60 nM。 | ||||
| GC17765 | Naftopidil DiHCl | 57149-08-3 | - | |
Naftopidil DiHCl (KT-611 dihydrochloride) 是一种选择性 alpha1-adrenoceptor 拮抗剂,对克隆人 α1a-, ⋱1b- 和 α1d-adrenoceptor subtypes 的 Kis 分别为 3.7 nM,20 nM 和 1.2 nM。 Naftpidil DiHCl 具有抗增殖作用。 Naftpidil DiHCl可用于前列腺增生的研究。 | ||||
| GC17769 | Sitaxentan sodium | 210421-74-2 | >98.00% | |
Sitaxentan sodium是一种选择性内皮素A受体(ETA)拮抗剂(IC 50 = 1.4nM;K i = 0.43nM)。 | ||||
| GC17771 | VS-5584 (SB2343) | 1246560-33-7 | >98.00% | |
A selective PI3K/mTOR kinase inhibitor | ||||
| GC17775 | NU 1025 | 90417-38-2 | >98.00% | |
An inhibitor of PARP | ||||
| GC17776 | Asaraldehyde | 4460-86-0 | >99.50% | |
Asarylaldehyde (Asaronaldehyde) 是一种 COX-2 抑制剂,可显着抑制环氧合酶 II (COX-2) 的活性,IC50 值为 100 μg/mL。 | ||||
| GC17778 | TAME | 901-47-3 | >98.00% | |
TAME 是后期促进复合物/环体(APC/C 或 APC)的抑制剂,它与 APC/C 结合并阻止其被 Cdc20 和 Cdh1 激活,产生有丝分裂停滞。 TAME 不具有细胞渗透性。 | ||||
| GC17783 | Veliparib dihydrochloride | 912445-05-7 | >99.50% | |
An orally bioavailable inhibitor of PARP1 and PARP2 | ||||
| GC17785 | Macitentan | 441798-33-0 | >99.50% / >99.00% | |
A dual ET A /ET B receptor antagonist | ||||
| GC17793 | UNC2250 | 1493694-70-4 | >98.00% | |
A selective Mer kinase inhibitor | ||||
| GC17794 | Diperodon HCl | 537-12-2 | - | |
Diperodon是一种局部麻醉剂,通过血清中水解酶的作用被分解。 | ||||
| GC17799 | Betrixaban | 330942-05-7 | >98.00% | |
A Factor Xa inhibitor | ||||
| GC17801 | PYZD-4409 | 423148-78-1 | >98.00% | |
PYZD-4409 是泛素激活酶 UBA1 的特异性抑制剂,IC50 为 20 μM(无细胞酶测定)。 PYZD-4409 在恶性细胞中诱导细胞死亡并优先抑制原发性急性髓细胞白血病细胞的克隆形成。 | ||||
| GC17802 | MK-4827 | 1038915-60-4 | >99.50% / >98.00% | |
MK-4827是具有口服活性的PARP抑制剂,可同时抑制PARP1(IC 50 =3.8nM)和PARP2(IC 50 =2.1nM),MK-4827可抑制PARP酶来阻断DNA修复,诱导癌细胞死亡。 | ||||
| GC17804 | GlyH-101 | 328541-79-3 | >98.00% | |
A reversible CFTR channel blocker | ||||
| GC17807 | TCS 1102 | 916141-36-1 | >99.50% | |
A dual orexin receptor antagonist | ||||
| GC17808 | Zolmitriptan | 139264-17-8 | >99.50% / >98.00% | |
An agonist of 5-HT 1B and 5-HT 1D receptors | ||||
| GC17817 | SC 58125 | 162054-19-5 | - | |
A selective COX-2 inhibitor | ||||
| GC17825 | Methscopolamine | 155-41-9 | - | |
A muscarinic acetylcholine receptor antagonist | ||||
| GC17830 | IMD 0354 | 978-62-1 | >99.50% | |
An IKKβ (IKK2) inhibitor | ||||
| GC17836 | ITF2357 (Givinostat) | 732302-99-7 | >98.00% | |
HDAC inhibitor with anti-inflammatory and antineoplastic activities | ||||
| GC17837 | DMAT | 749234-11-5 | >98.00% | |
A cell-permeable inhibitor of CK2 | ||||
| GC17848 | Penciclovir | 39809-25-1 | >99.00% | |
An antiviral guanosine analog | ||||
